Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The impact of direct-acting antiviral agents on liver and kidney transplant costs and outcomes
David A. Axelrod, Mark A. Schnitzler, Tarek Alhamad, et al.
American Journal of Transplantation (2018) Vol. 18, Iss. 10, pp. 2473-2482
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Transplantation of kidneys from hepatitis C–infected donors to hepatitis C–negative recipients: Single center experience
Miklos Z. Molnar, Satheesh Nair, Orsolya Cseprekál, et al.
American Journal of Transplantation (2019) Vol. 19, Iss. 11, pp. 3046-3057
Open Access | Times Cited: 119
Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)‐Viremic Donors Into HCV‐Negative Recipients: Outcomes Following Liver Transplant of HCV‐Viremic Donors
Thomas G. Cotter, Sonali Paul, Burhaneddin Sandıkçı, et al.
Hepatology (2019) Vol. 69, Iss. 6, pp. 2381-2395
Closed Access | Times Cited: 116
Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct‐Acting Antiviral Era
Thomas G. Cotter, Sonali Paul, Burhaneddin Sandıkçı, et al.
Liver Transplantation (2019) Vol. 25, Iss. 4, pp. 598-609
Closed Access | Times Cited: 80
National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys
Vishnu S. Potluri, David S. Goldberg, Sumit Mohan, et al.
Journal of the American Society of Nephrology (2019) Vol. 30, Iss. 10, pp. 1939-1951
Open Access | Times Cited: 72
Center-level trends in utilization of HCV-exposed donors for HCV-uninfected kidney and liver transplant recipients in the United States
Mary G. Bowring, Ashton A. Shaffer, Allan B. Massie, et al.
American Journal of Transplantation (2019) Vol. 19, Iss. 8, pp. 2329-2341
Open Access | Times Cited: 43
Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy
Mary G. Bowring, Lauren M. Kucirka, Allan B. Massie, et al.
Transplantation (2018) Vol. 102, Iss. 12, pp. 2088-2095
Open Access | Times Cited: 38
The association of donor hepatitis C virus infection with 3-year kidney transplant outcomes in the era of direct-acting antiviral medications
Siobhan Sutcliffe, Mengmeng Ji, Su‐Hsin Chang, et al.
American Journal of Transplantation (2023) Vol. 23, Iss. 5, pp. 629-635
Open Access | Times Cited: 12
Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus–Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study
Deirdre Sawinski, Kimberly A. Forde, Vincent Lo Re, et al.
American Journal of Kidney Diseases (2019) Vol. 73, Iss. 6, pp. 815-826
Open Access | Times Cited: 33
The Changing Face of Liver Transplantation in the United States: The Effect of HCV Antiviral Eras on Transplantation Trends and Outcomes
Nicholas F. Parrish, Irene D. Feurer, Lea Matsuoka, et al.
Transplantation Direct (2019) Vol. 5, Iss. 3, pp. e427-e427
Open Access | Times Cited: 31
Survey of Clinician Opinions on Kidney Transplantation from Hepatitis C Virus Positive Donors: Identifying and Overcoming Barriers
Krista L. Lentine, John Devin Peipert, Tarek Alhamad, et al.
Kidney360 (2020) Vol. 1, Iss. 11, pp. 1291-1299
Open Access | Times Cited: 27
Disparity in access to kidney allograft offers among transplant candidates with human immunodeficiency virus
Jordana B. Cohen, Jayme E. Locke, Brittany A. Shelton, et al.
Clinical Transplantation (2018) Vol. 33, Iss. 2
Open Access | Times Cited: 26
Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?
Robert M. Cannon, Jayme E. Locke, Babak J. Orandi, et al.
Transplantation (2019) Vol. 104, Iss. 6, pp. 1215-1228
Open Access | Times Cited: 21
Lessons from the real world: HCV-infected donor kidney transplantation as standard practice
Christine M. Durand, Michael A. Chattergoon, Niraj M. Desai
American Journal of Transplantation (2019) Vol. 19, Iss. 11, pp. 2969-2970
Open Access | Times Cited: 18
Population level outcomes and cost-effectiveness of hepatitis C treatment pre- vs postkidney transplantation
Brittany A. Shelton, Deirdre Sawinski, Benjamin P. Linas, et al.
American Journal of Transplantation (2018) Vol. 18, Iss. 10, pp. 2483-2495
Open Access | Times Cited: 15
Outcomes of liver transplantation for nonalcoholic steatohepatitis-associated hepatocellular carcinoma
Matthew L. Holzner, Sander Florman, Myron Schwartz, et al.
HPB (2021) Vol. 24, Iss. 4, pp. 470-477
Closed Access | Times Cited: 12
Liver transplantation for hepatitis C patients in the era of direct-acting antiviral treatment: A retrospective cohort study
Adeel S. Khan, Nathaniel Adams, Neeta Vachharajani, et al.
International Journal of Surgery (2020) Vol. 75, pp. 84-90
Closed Access | Times Cited: 12
Organ Donors with Human Immunodeficiency Virus and Hepatitis C Virus
Jordan Salas, Kaitlyn Storm, Christine M. Durand
Infectious Disease Clinics of North America (2023) Vol. 37, Iss. 3, pp. 641-658
Closed Access | Times Cited: 4
Optimal timing of hepatitis C treatment among HIV/HCV coinfected ESRD patients: Pre- vs posttransplant
Brittany A. Shelton, Gideon J. Berdahl, Deirdre Sawinski, et al.
American Journal of Transplantation (2018) Vol. 19, Iss. 6, pp. 1806-1819
Open Access | Times Cited: 12
Lower Likelihood of Post-transplant Graft Failure, Death, and Retransplantation in the Era of Direct-Acting Antivirals
Kellie Young, Benny Liu, Taft Bhuket, et al.
Journal of Clinical and Experimental Hepatology (2020) Vol. 10, Iss. 6, pp. 581-589
Open Access | Times Cited: 11
Infectious Complications Following Kidney Transplantation—A Focus on Hepatitis C Infection, Cytomegalovirus Infection and Novel Developments in the Gut Microbiota
Samuel Chan, Nicole M. Isbel, Carmel M. Hawley, et al.
Medicina (2019) Vol. 55, Iss. 10, pp. 672-672
Open Access | Times Cited: 10
Kidney Transplantation in Patients with HIV
Deirdre Sawinski
Kidney360 (2020) Vol. 1, Iss. 7, pp. 705-711
Open Access | Times Cited: 10
Transplantation of Organs from Hepatitis C Virus-Positive Donors under Direct-Acting Antiviral Regimens
Muhammad Zahid
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 770-770
Open Access | Times Cited: 6
National trends and outcomes of heart‐kidney transplantation using hepatitis C positive donors
Carlos E. Díaz-Castrillón, Lauren V. Huckaby, Lucas Witer, et al.
Clinical Transplantation (2022) Vol. 36, Iss. 4
Closed Access | Times Cited: 5
Direct-Acting Antivirals and Organ Transplantation: Is There Anything We Can’t Do?
Matthew R. Kappus, Cameron R. Wolfe, Andrew J. Muir
The Journal of Infectious Diseases (2020) Vol. 222, Iss. Supplement_9, pp. S794-S801
Open Access | Times Cited: 7
Hepatitis C virus and kidney transplantation: Recent trends and paradigm shifts
Guy El Helou, Colleen L. Jay, Marina Núñez
Transplantation Reviews (2022) Vol. 36, Iss. 1, pp. 100677-100677
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top